617
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Continuous terbutaline infusion in severe asthma in adults: a retrospective study of long-term efficacy and safety

, PhD, FRCP, , RGN, , RGN, , OBE & , MD, FRCP
Pages 1076-1082 | Received 09 Jan 2014, Accepted 23 Jun 2014, Published online: 11 Aug 2014

References

  • British Thoracic Society Scottish Intercollegiate Guidelines Network. The British Guideline on the Management of Asthma. Thorax 2008;63:1–121
  • Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, Bel E, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS task force on difficult/therapy-resistant. Eur Respir J 1999;13:1198–1208
  • Serra-Battles J, Plaxa V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 1998;12:1322–1326
  • Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, et al. Benefits of Omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005;60:309–316
  • O’Driscoll BRC, Ruffles SP, Ayres JG, Wiggins J, Cochrane GM, Skinner C. Long term treatment of severe asthma with subcutaneous terbutaline. Br J Dis Chest 1988;82:360–367
  • Ayres JG, Fish DR, Wheeler DC, et al. Subcutaneous terbutaline and control of brittle asthma or appreciable morning dipping. Br Med J (Clin Res Ed) 1984;288:1715–1716
  • Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998;53:315–321
  • Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010;138:682–692
  • Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715–1721
  • Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218–224
  • Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D'Agostino R Jr, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 2010;181:315–323
  • Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, Cox G. Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol 2011;107:65–70
  • Aaron SD, Dales RE, Pham B. Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomized clinical trials. Respir Med 1998;92:1059–1065
  • Barnes N, Menzies-Gow A, Mansur AH, Spencer D, Percival F, Radwan A, Niven R. Effectiveness of omalizumab in severe allergic asthma: a retrospective UK real-world study. J Asthma 2013;50:529–536
  • Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, Chung KF, et al; RISA Trial Study Group. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med 2007;176:1185–1191
  • Greefhorst AP, van Herwaarden CL. Ventilatory and haemodynamic effects of terbutaline infusion during beta 1-selective blockade with metoprolol and acebutolol in asthmatic patients. Eur J Clin Pharmacol 1982;23:203–208
  • Kendall MJ. Are selective beta-adrenoceptor blocking drugs an advantage? J R Coll Physicians Lond 1981;15:33–40
  • Petch MC, McKay R, Bethune DW. The effect of beta, adrenergic blockade on serum potassium and glucose levels during open heart surgery. Eur Heart J 1981;2:123–126
  • Kripke C. Use of beta agonists in preterm labor. Am Fam Physician 2005;71:899–900. Review
  • Casper RF and Lye SJ. Myometrial desensitization to continuous but not to intermittent beta-adrenergic agonist infusion in the sheep. Am J Obstet Gynecol 1986;154:301–305
  • Kurland G, Williams J, Lewiston NJ. Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma. J Allergy Clin Immunol 1979;63:407–411
  • Sykes AP, Lawson N, Finnegan JA, Ayres JG. Creatine kinase activity in patients with brittle asthma treated with long term subcutaneous terbutaline. Thorax 1991;46:580–583
  • Kambalapalli M, Nichani S, Upadhyayula S. Safety of intravenous terbutaline in acute severe asthma: a retrospective study. Acta Paediatr 2005;94:1214–1217
  • Kendall MJ, Dean S, Bradley D, Worthington DJ. Cardiovascular and metabolic effects of terbutaline. J Clin Hosp Pharm 1982;7:31–36
  • Lewis LD, O’Driscoll BR, Hartley RB, Cochrane GM. An unusual local reaction to continuous subcutaneous infused terbutaline in unstable asthmatics. Br J Dis Chest 1987;81:189–193
  • Everill JA, Gupta D, Anees W, Baker C, Ayres JG. Audit of long term central venous access devices in patients with Type 1 brittle asthma. Asthma J 2001;6:20–26
  • Lyte M, Freestone PP, Neal CP, Olson BA, Haigh RD, Bayston R, Williams PH. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet 2003;361:130–135
  • Mansur AH, Pooler A. Psychological morbidity in difficult to treat asthma. In: Heaney LG, Menzies-Gow A, eds. Clinical focus series: difficult asthma. New Delhi, India: JAYPEE Brothers Medical Publishers (P) Ltd; 2013:56–71
  • Niven R. Comorbidities in refractory asthma. In: Heaney LG, Menzies-Gow A, eds. Clinical focus series: difficult asthma. New Delhi, India: JAYPEE Brothers Medical Publishers (P) Ltd; 2013:102–119

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.